Melody Hu, MD, MHS
Assistant Professor
Psychiatry
School of Medicine

Education & Training

Show all (3) Hide

• Adult Residency UCSF Dept. of Psychiatry 06/2022
• MD Yale School of Medicine 05/2018
• MHS Yale School of Medicine 05/2018

Publications (4)

Top publication keywords:
RewardImmunotherapyLeukomalacia, PeriventricularRats, Long-EvansCerebral CortexAnhedoniaNervous System DiseasesPrefrontal CortexStress, PsychologicalBumetanideSolute Carrier Family 12, Member 2Sodium Potassium Chloride Symporter InhibitorsWhite MatterOligodendrogliaAutoimmune Diseases

• A Feasibility Study of a Remotely-Delivered Mindfulness-Based Training for Adolescents During the COVID-19 Pandemic.
  Frontiers in psychiatry 2022 Tymofiyeva O, Hu MY, Sipes BS, Jakary A, Glidden DV, Jariwala N, Bhandari S, Parks KC, Nguyen C, Henje E, Yang TT
• Cumulative Effects of Social Stress on Reward-Guided Actions and Prefrontal Cortical Activity.
  Biological psychiatry 2020 Barthas F, Hu MY, Siniscalchi MJ, Ali F, Mineur YS, Picciotto MR, Kwan AC
• Current and future immunotherapy targets in autoimmune neurology.
  Handbook of clinical neurology 2016 Hu MY, Stathopoulos P, O'connor KC, Pittock SJ, Nowak RJ
• Chloride cotransporter NKCC1 inhibitor bumetanide protects against white matter injury in a rodent model of periventricular leukomalacia.
  Pediatric research 2015 Jantzie LL, Hu MY, Park HK, Jackson MC, Yu J, Maxwell JR, Jensen FE